###begin article-title 0
Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 80 81 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 79 81 79 81 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 851 852 851 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 850 852 850 852 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 1065 1066 1065 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1064 1066 1064 1066 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 624 629 <span type="species:ncbi:9606">human</span>
Olopatadine hydrochloride (olopatadine) is an antiallergic drug with histamine H1 receptor antagonistic activity. Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts multiple proinflammatory activities including chemotaxis for monocytes and neutrophils. In this study, we examined the possibility that the interaction of olopatadine with S100A12 inhibits the proinflammatory effects of S100A12. Pretreatment of olopatadine with S100A12 reduced migration of THP-1, a monocyte cell line, induced by S100A12 alone, but did not affect recombinant human regulated upon activation, normal T cell expressed and secreted (RANTES)-induced migration. Amlexanox, which also binds to S100A12, inhibited the THP-1 migration induced by S100A12. However, ketotifen, another histamine H1 receptor antagonist, had little effect on the activity of S100A12. These results suggest that olopatadine has a new mechanism of action, that is, suppression of the function of S100A12, in addition to histamine H1 receptor antagonistic activity.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 228 230 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 226 230 226 230 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ca<sup>2+</sup></chem-struct>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 711 712 711 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 774 782 <span type="species:ncbi:9606">patients</span>
S100A12 belongs to the S100 family of EF-hand-type calcium-binding proteins [1]. These proteins are involved in the regulation of a variety of intracellular activities, including protein phosphorylation, enzymatic activities, Ca2+ homeostasis, and intermediate filament polymerization [2]. On the other hand, several S100 proteins including S100A12 are secreted and have extracellular activities [2]. S100A12 belongs to a subset of the S100 protein family, which is termed the myeloid-related proteins (MRPs) [3-5], because expression of these proteins is almost completely restricted to cells of myeloid origin, such as neutrophils and monocytes. MRPs have proinflammatory effects in the extracellular milieu [6, 7]. S100A12 is detected in the synovial fluid and plasma of patients with gout, rheumatoid arthritis, and psoriatic arthritis [8], suggesting that S100A12 may be involved in the inflammation in these diseases.
###end p 4
###begin p 5
###xml 383 384 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 518 519 507 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 762 763 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 893 895 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 897 899 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 13 19 <span type="species:ncbi:9913">bovine</span>
###xml 489 495 <span type="species:ncbi:10090">murine</span>
###xml 543 549 <span type="species:ncbi:9913">bovine</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 671 677 <span type="species:ncbi:10090">murine</span>
###xml 740 746 <span type="species:ncbi:9913">bovine</span>
###xml 779 784 <span type="species:ncbi:9606">human</span>
S100A12 from bovine lung extract was identified as a ligand for the receptor for advanced glycation end products (RAGE), which is expressed on macrophages, endothelium, and lymphocytes. Endothelial cells incubated with S100A12 exhibited increased expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 through the activation of nuclear factor-kappa B [9]. In addition, S100A12 induced the expression of tumor necrosis factor-alpha and interleukin-1beta in a murine macrophage cell line [8]. Footpad injection of bovine S100A12 into mice resulted in the infiltration of leukocytes, and anti-S100A12 antibody blocked leukocyte recruitment in murine models of delayed-type hypersensitivity induced by methylated bovine serum albumin [9]. Furthermore, human recombinant S100A12 has been reported to be chemotactic for neutrophils and monocytes in vitro and in vivo [10, 11]. Thus, S100A12 and RAGE are attractive targets for the treatment of inflammation.
###end p 5
###begin p 6
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
It has been reported that anti-allergic drugs/mast cell stabilizers such as amlexanox and cromolyn specifically bind to S100A12 and S100A13 which are another member of the S100 protein family [12]. It has also been reported that amlexanox repressed the fibroblast growth factor 1 (FGF-1) release induced by S100A13 [13, 14]. Therefore, it is expected that binding of these drugs to S100A12 result in the inhibition of its function, which may contribute to antiallergic or anti-inflammatory effects of these drugs.
###end p 6
###begin p 7
###xml 148 151 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 228 229 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 227 229 225 227 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 449 451 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 801 803 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 893 895 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1023 1025 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 1027 1029 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 749 754 <span type="species:ncbi:9606">human</span>
###xml 951 954 <span type="species:ncbi:10116">rat</span>
###xml 977 981 <span type="species:ncbi:10090">mice</span>
Olopatadine hydrochloride (olopatadine: (Z)-11-(3-Dimethylaminopropylidene)-6,11-dihydrodibenz [b,e]oxepin-2-acetic acid monohydrochloride, ALLELOCK(R), Kyowa Hakko Kogyo Co, Ltd, Japan) is an antiallergic agent with histamine H1 receptor antagonistic action that is indicated for the signs and symptoms of allergic rhinitis, chronic urticaria, eczema dermatitis, prurigo, pruritis cutaneous, psoriasis vulgaris, and erythema exsudativum multiform [15]. Olopatadine exhibits potent antihistamine activity in vivo following its systemic administration. In addition to its potent antihistaminic effect, previous studies have demonstrated that olopatadine inhibits the release of inflammatory lipid mediators such as leukotrienes and thromboxanes from human polymorphonuclear leukocytes and eosinophils [15]. Olopatadine also reduces the tachykinin release from peripheral sensory nerve endings [16]. Olopatadine inhibits eosinophil infiltration in both rat allergic rhinitis and mice chronic contact hypersensitivity models [17, 18]. However, the precise mechanism of inhibitory effects of olopatadine on infiltration of leukocytes is still unclear.
###end p 7
###begin p 8
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 259 264 <span type="species:ncbi:9606">human</span>
Recently, Okada et al have found that olopatadine binds specifically to S100A12 and S100A13 in a calcium-dependent manner as amlexanox and cromolyn do [19]. In the present study, we examined the inhibitory effect of olopatadine on the function of recombinant human S100A12.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Materials
###end title 10
###begin p 11
###xml 229 232 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 351 356 <span type="species:ncbi:9606">human</span>
Olopatadine hydrochloride (olopatadine) was synthesized in Yokkaichi Plant, Kyowa Yuka Co, Ltd (Mie, Japan). Ketotifen fumarate (ketotifen) was purchased from Sigma Chemical (St Louis, Mo, USA). Amlexanox was extracted from SOLFA(R) tablets purchased from Takeda Chemical Industries Inc (Osaka, Japan). These drugs were dissolved in DMSO. Recombinant human regulated upon activation, normal T cell expressed and secreted (RANTES) was purchased from R&D SYSTEMS (Minneapolis, Minn, USA).
###end p 11
###begin title 12
Recombinant S100A12 protein
###end title 12
###begin p 13
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 534 537 519 522 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCl</chem-struct>
###xml 697 700 682 685 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCl</chem-struct>
###xml 904 908 889 893 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaCl</chem-struct>
###xml 1265 1269 1250 1254 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaCl</chem-struct>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human S100A12 cDNA was a gift from Dr Ryoji Kobayashi (Department of Signal Transduction Sciences, Kagawa University Faculty of Medicine, Kagawa, Japan). Recombinant protein was expressed in E coli strain BL21 (DE3) and purified as previously described by Yamashita et al [20], with some modifications. Briefly, 300 mL DE3 culture was grown at 37degreesC to an OD600 of 0.6-0.8 and induced with 1 mmol/L isopropyl-beta-D-thiogalactopyranoside for 4 h at 37degreesC. The cell pellet was resuspended in hypotonic buffer, 10 mmol/L Tris-HCl (pH 7.5) containing 1 mmol/L ethylenediaminetetraacetic acid, and then centrifuged at 10 000 g for 60 min. The supernatant was dialyzed against 20 mmol/L Tris-HCl (pH 7.5) (buffer A), and loaded onto a HiPrep 16/10 Q XL column (Amersham Biosciences, Piscataway, NJ, USA) equilibrated with buffer A. The protein was eluted with a linear gradient from 0 to 250 mmol/L NaCl. Fractions containing the protein were pooled and loaded onto a HiLoad 16/60 Superdex 75 pg (Amersham Biosciences) equilibrated with buffer A. Fractions containing the protein were pooled and further purified using a Mono Q HR 5/5 column (Amersham Biosciences) equilibrated with buffer A. The protein was eluted with a linear gradient from 0 to 200 mmol/L NaCl, and stored at -80degreesC. Purity was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In S100- A12 preparations used for this study, endotoxin levels were less than 0.1 pg/mug of S100A12 as measured by the limulus amebocyte assay (Bio Whittaker, Walkersville, Md, USA).
###end p 13
###begin title 14
Cell culture
###end title 14
###begin p 15
###xml 314 315 307 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 312 315 305 308 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CO<sub>2</sub></chem-struct>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 158 164 <span type="species:ncbi:9913">bovine</span>
Human monocytic THP-1 cells (American Type Culture Collection, Manassas, Va, USA) were cultured in RPMI 1640 supplemented with 10 vol% heat-inactivated fetal bovine serum (FBS) (Cansera, Etobicoke, ON, Canada), 100 U/mL penicillin and 100 mug/mL streptomycin (Invitrogen, Grand Island, NY, USA) at 37degreesC 5% CO2 in air.
###end p 15
###begin title 16
Cell migration assay
###end title 16
###begin p 17
###xml 641 642 634 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 725 726 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 723 726 710 713 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CO<sub>2</sub></chem-struct>
The migration of THP-1 monocytes was studied using a Chemotaxicell 24-well disposable chamber with 5 mum pores (Kurabo Industries Ltd, Osaka, Japan). Cultured cells were harvested and washed three times with Hank's balanced salt solution and then re-suspended in assay medium (RPMI 1640 with 0.5 vol% heat-inactivated FBS, 10 mmol/L N-(2-hydroxyethyl)piperazine-N'-(4-butanesulfonic acid), pH 7.4). Each drug and stimulant were premixed in the assay medium and incubated at 37degreesC for 30 min. Then 0.05 mL of the mixture was placed into the lower chamber contained 0.45 mL/well of the assay medium. Then 0.2 mL of cell suspension (6 x 105 cells) was added to the upper chamber and incubated for 3 h at 37degreesC in 5% CO2. Cells passing through the membrane were collected from the lower well and counted with the EPICS XL/MCL flow cytometry system (Beckman Coulter, Fullerton, Calif, USA) followed by mixing of a predetermined number of flow-count fluorospheres (Beckman Coulter). The total number of cells that had migrated to the lower wells was determined by the ratio of cells to fluorospheres using the following formula: cells per microliter = [(cells counted)/(fluorospheres counted)] x fluorospheres/microliter. Each sample was assayed in triplicate.
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 49 50 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 267 268 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data were presented as means +/- SE. The Student t test following the F-test was used for analysis of differences between two groups. Multiple comparisons among treatment groups were assessed by one-way analysis of variance, followed by the Dunnett's test. Values of P < .05 were considered statistically significant. All statistical calculations were performed with the Statistical Analysis System (SAS Institute, Cary, NC, USA).
###end p 19
###begin title 20
RESULTS
###end title 20
###begin title 21
Effects of olopatadine on the migration of THP-1 monocytes induced by S100A12 or RANTES
###end title 21
###begin p 22
###xml 529 540 522 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1(a)</xref>
###xml 642 653 635 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1(b)</xref>
###xml 668 679 661 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1(a)</xref>
###xml 1071 1082 1064 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1(b)</xref>
The migration of THP-1 monocytes was studied in the presence of S100A12 or RANTES. S100A12 induced the migration of THP-1 cells at concentrations between 0.75 and 2 mumol/L (data not shown). Therefore, we examined the effect of olopatadine on the activity of S100A12 at 1 mumol/L, a submaximal concentration. After pretreatment of S100A12 for 30 min, 26095 +/- 1044 cells/well migrated to the bottom chamber at 1 mumol/L of S100A12, indicating a 3.4-fold increase in comparison with the control value of 7699 +/- 693 cells/well (Figure 1(a)). On the other hand, RANTES caused a 6.0-fold increase in the migration of THP-1 cells at 10 nmol/L (Figure 1(b)). As shown in Figure 1(a), pretreatment of S100A12 with olopatadine resulted in a concentration-dependent reduction of THP-1 cell migration induced by S100A12, although the reduction was only partial. The reduction of THP-1 cell migration by olopatadine is apparently not caused by inhibition of cell motility, since parallel studies showed that olopatadine had no effect on the migration of cells induced by RANTES (Figure 1(b)).
###end p 22
###begin title 23
Effect of amlexanox on THP-1 migration induced by S100A12
###end title 23
###begin p 24
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 269 277 269 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
Amlexanox is also reported to bind to S100A12 [12]. In addition, it has already been reported that amlexanox binds to S100A13 and represses the FGF-1 release induced by S100A13 [13, 14]. Accordingly, it is expected that amlexanox also inhibits the function of S100A12. Figure 2 shows that amlexanox suppressed THP-1 migration induced by S100A12 more efficiently than olopatadine. While amlexanox suppressed the THP-1 migration induced by RANTES to some extent (data not shown), it was weak in this respect compared with inhibition of migration by S100A12. It is likely that amlexanox suppresses the effect of S100A12 by binding to S100A12 rather than by inhibiting cell motility.
###end p 24
###begin title 25
Effects of ketotifen on the migration of THP-1 cells induced by S100A12 or RANTES
###end title 25
###begin p 26
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 37 39 37 39 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 166 167 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 165 167 165 167 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 201 209 201 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 388 389 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 387 389 386 388 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
###xml 439 441 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 443 445 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 562 563 561 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 561 563 560 562 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
Next, to determine whether histamine H1 receptor antagonistic activity of olopatadine is related inhibition of the activity of S100A12, ketotifen, another histamine H1 receptor antagonist, was tested. Figure 3 shows that ketotifen (50 mumol/L) did not affect THP-1 migration induced by either S100A12 and RANTES, though it has already been shown that ketotifen has more potent histamine H1 receptor antagonistic activity than olopatadine [21, 22]. These results suggest that olopatadine directly binds to S100A12 and inhibits its function rather than histamine H1 receptor antagonistic activity.
###end p 26
###begin title 27
DISCUSSION
###end title 27
###begin p 28
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 413 418 <span type="species:ncbi:9606">human</span>
S100A12 has been identified as a binding protein to antiallergic drugs, such as olopatadine, amlexanox, and cromolyn, using drug-affinity columns [19]. S100A12 has multiple inflammatory effects [8-11]. If these drugs suppress the activity of S100A12, a new anti-inflammatory mechanism of action of these drugs can be demonstrated. In the present study, we confirmed that S100A12 induced the migration of THP-1, a human monocytic cell line, at 1 mumol/L, and then that olopatadine and amlexanox suppressed this migration. Moreover, these drugs had little effect on the migration of THP-1 cells induced by RANTES, suggesting that olopatadine and amlexanox bind to S100A12 specifically and suppress its activity.
###end p 28
###begin p 29
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Previous studies showed that S100A12 induced chemotactic responses at much lower concentrations (0.01-1 nmol/L) [9, 10], whereas no response to S100A12 at lower concentrations was detected in our experiments. Recently, x-ray analysis has revealed two crystal forms of recombinant S100A12 [21]. Therefore, the effective concentration of S100A12 may vary according to experimental conditions. It is possible that in some conditions lesser amounts of drugs are sufficient for suppression of the activity of. In fact, it is necessary to examine the effect of olopatadine on the function of S100A12 in vivo experiments.
###end p 29
###begin p 30
###xml 289 290 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 288 290 288 290 <chem-struct xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H<sub>1</sub></chem-struct>
Ketotifen in contrast to olopatadine did not suppress the THP-1 migration induced by S100A12, suggesting that olopatadine may have the distinctive feature of direct inhibition of the function of S100A12. This new mechanism of action of olopatadine may in addition to its potent histamine H1 receptor antagonistic activity provide high degree of efficacy in the treatment of allergic diseases.
###end p 30
###begin title 31
ACKNOWLEDGMENT
###end title 31
###begin p 32
###xml 125 130 <span type="species:ncbi:9606">human</span>
We thank Dr Ryoji Kobayashi (Department of Signal Transduction Sciences, Kagawa University, Kagawa, Japan) for providing the human S100A12 cDNA.
###end p 32
###begin article-title 33
The S100 family of EF-hand calcium-binding proteins: functions and pathology
###end article-title 33
###begin article-title 34
Identification of intracellular target proteins of the calciumsignaling protein S100A12
###end article-title 34
###begin article-title 35
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin
###end article-title 35
###begin article-title 36
###xml 82 87 <span type="species:ncbi:9606">human</span>
Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils
###end article-title 36
###begin article-title 37
The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces
###end article-title 37
###begin article-title 38
The heterodimeric complex of MRP-8 (S100A8) and MRP-14 (S100A9). Antibody recognition, epitope definition and the implications for structure
###end article-title 38
###begin article-title 39
Acute inflammatory activity of the S100 protein CP-10. Activation of neutrophils in vivo and in vitro
###end article-title 39
###begin article-title 40
###xml 34 39 <span type="species:ncbi:9606">human</span>
Proinflammatory properties of the human S100 protein S100A12
###end article-title 40
###begin article-title 41
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides
###end article-title 41
###begin article-title 42
###xml 53 58 <span type="species:ncbi:9606">human</span>
Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE)
###end article-title 42
###begin article-title 43
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis
###end article-title 43
###begin article-title 44
Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family
###end article-title 44
###begin article-title 45
S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro
###end article-title 45
###begin article-title 46
The intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to export
###end article-title 46
###begin article-title 47
Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug
###end article-title 47
###begin article-title 48
###xml 139 143 <span type="species:ncbi:10116">rats</span>
Effects of olopatadine hydrochloride on the cutaneous vascular hyperpermeability and the scratching behavior induced by poly-L-arginine in rats
###end article-title 48
###begin article-title 49
Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils
###end article-title 49
###begin article-title 50
###xml 138 142 <span type="species:ncbi:10090">mice</span>
Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice
###end article-title 50
###begin article-title 51
Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein
###end article-title 51
###begin article-title 52
###xml 16 22 <span type="species:ncbi:9913">bovine</span>
###xml 48 64 <span type="species:ncbi:562">Escherichia coli</span>
Purification of bovine S100A12 from recombinant Escherichia coli
###end article-title 52
###begin article-title 53
Affinity of KW-4679, a novel antiallergic drug, for various receptors and ex vivo histamine H1 receptors
###end article-title 53
###begin article-title 54
Multiple structural states of S100A12: A key to its functional diversity
###end article-title 54
###begin title 55
Figures and Tables
###end title 55
###begin p 56
###xml 303 304 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 383 384 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 393 394 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 406 407 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Effects of olopatadine on the migration of THP-1 cells induced by S100A12 (a) or RANTES (b). The numbers of cells migrating toward S100A12 (1 mumol/L) or RANTES (10 nmol/L) during 3 h incubation were determined by flow cytometry. The values in panel (a) are means +/- SE from 3 independent experiments (n = 9), and those in panel (b) are means +/- SE from 2 independent experiments (n = 6). **P < 0.01; ***P < 0.001 (versus control, Dunnett's test). Media, spontaneous migration.
###end p 56
###begin p 57
Comparison of the abilities of olopatadine (open circle) and amlexanox (closed circle) to inhibit THP-1 migration induced by S100A12. Migration assay was performed as described for the prior experiments. Values are percentages of control, and are the means of 2 independent experiments.
###end p 57
###begin p 58
###xml 278 279 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 287 288 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 321 322 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Effects of olopatadine or ketotifen on the migration of THP-1 cells induced by S100A12 (a) or RANTES (b). The numbers of cells migrating toward S100A12 (1 mumol/L) or RANTES (10 nmol/L) during 3 h incubation were counted. Values are means +/- SE from 2 independent experiments (n = 6). *P < 0.05 (versus control, Student t test). Media, spontaneous migration.
###end p 58

